Expert perspectives on life sciences strategy, commercialization, and market dynamics.
Expert perspectives on life sciences strategy, commercialization, and market dynamics.
The oncology landscape is expanding at an unprecedented pace and major breakthroughs are creating more possibilities. But quality innovation alone is no longer enough to guarantee commercial success, and the oncology pipeline is crowded. Manufacturers must solidify their strategic positioning early in order to win market share. Driver of pipeline congestion include: Newly druggable targets: […]
Planning a new product launch can be challenging. From assessing market needs to aligning cross-functional teams, companies must follow proven strategies to ensure a smooth, successful launch that meets commercial and compliance expectations.
Novel therapies entering established oncology markets face steep adoption barriers when clinical pathways are already entrenched. Overcoming this resistance requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as embedding into clinical pathways, managing safety expectations, or expanding into earlier lines of therapy through post-launch […]
Novel therapies entering overlooked disease categories often encounter steep adoption barriers when conditions remain underdiagnosed and unfamiliar to prescribers. Overcoming this resistance requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as building diagnostic pathways, educating specialists on disease recognition, or establishing outcomes-based agreements with […]
Clinically differentiated therapies entering mature markets often face steep adoption resistance when high launch prices collide with aggressive payer restrictions. Overcoming this friction requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as realigning pricing to alleviate payer resistance, or generating outcomes validation to justify […]
Novel therapies entering previously untreated spaces often face steep adoption barriers when safety concerns or prescriber inertia arise. Overcoming this resistance requires establishing a strategic beachhead: a targeted focus area used to secure market traction, such as activating independent patient advocacy champions or publishing real-world surveillance data to resolve clinical skepticism. This case study is […]
Promising drugs often struggle early with slow uptake and missed sales targets. Achieving commercial traction requires securing a strategic beachhead: a targeted focus area such as concentrating on a guideline-backed patient group, eliminating a key payer barrier, or publishing real-world data to resolve prescriber hesitation. This case study is part of Triangle Insights Group’s series, […]
How Five Analog Brands Used Positioning, Advocacy, Evidence, and Access Levers for Launch and Beyond Pharmaceutical product launches are complex and critical to get right. In today’s environment, marked by heightened payer scrutiny, crowded markets, and compressed timelines for demonstrating value, even promising therapies often face slow uptake and missed forecasts in their earliest months. […]